$AIM
AIM ImmunoTech Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
AIM ImmunoTech Inc.
XASE•Health Care•Biological Products, (No Diagnostic Substances)
Why is AIM down today? It is at $0.115 (-4.50%), and our scanner flagged it 5 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment AIM spikes, and full due diligence on AIM — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $AIM 5 times in the last 30 days. Create a free account to track $AIM, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
The market is closed. Here is how AIM traded in the last session, Friday (last price and move above). Our scanner fired 1 unusual-volume and momentum alert on AIM on Friday, peaking at 69.9x its normal volume.
Likely catalystImmunoTech Announces Adjournment of 2026 Annual Meeting and Information for Reconvened Meeting, from an SEC filing. Read it →We could not reach SEC EDGAR, so the dilution check did not run. This is not a clean result - verify on EDGAR before trading.
Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
From the trading subreddits (WallStreetBets, r/stocks and more). Retail chatter, not a signal. Do your own research.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Equels Thomas K Officer | Bought (open market) | +50K 0.1% of company | added 13% | 436K | $7K at $0.130 | Nov 19, 26 |
Equels Thomas K Officer | Bought (open market) | +20K 0.05% of company | added 5.5% | 386K | $3K at $0.130 | Nov 18, 26 |
Kellner Ted D Director | Sold (automatic/other) | -18K 0.04% of company | sold 47% | 20K | $2K at $0.140 | Nov 18, 26 |
Equels Thomas K Officer | Bought (open market) | +38K 0.10% of company | added 12% | 366K | $5K at $0.140 | Nov 16, 26 |
Equels Thomas K Officer | Bought (open market) | +35K 0.09% of company | added 12% | 328K | $5K at $0.150 | Nov 11, 26 |
Equels Thomas K Officer | Bought (open market) | +39K 0.10% of company | added 15% | 293K | $5K at $0.140 | Nov 10, 26 |
Equels Thomas K Officer | Bought (open market) | +31K 0.08% of company | added 14% | 254K | $5K at $0.160 | Nov 9, 26 |
Equels Thomas K Officer | Bought (open market) | +20K 0.05% of company | added 11% | 210K | $3K at $0.160 | Nov 6, 26 |
Equels Thomas K Officer | Bought (open market) | +13K 0.03% of company | added 6.1% | 223K | $2K at $0.160 | Nov 6, 26 |
Equels Thomas K Officer | Bought (open market) | +32K 0.08% of company | added 20% | 190K | $5K at $0.160 | Oct 23, 26 |
Equels Thomas K Officer | Bought (open market) | +31K 0.08% of company | added 25% | 158K | $5K at $0.160 | Oct 22, 26 |
Equels Thomas K Officer | Bought (open market) | +24K 0.06% of company | added 23% | 127K | $5K at $0.210 | Sep 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in biological products, (no diagnostic substances), closest in size first.
The market is closed. Here is how AIM traded in the last session, Friday (last price and move above). Our scanner fired 1 unusual-volume and momentum alert on AIM on Friday, peaking at 69.9x its normal volume.
AIM last traded at $0.115, down 4.50% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
The AIM Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged AIM 5 times in the last 30 days.
AIM (AIM ImmunoTech Inc.) trades on XASE, with a market cap of about $5M in the Biological Products, (No Diagnostic Substances) sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge AIM for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
Measured from the first close after the split, AIM went from $1.29 to $0.11 by Nov 20, 2026, down 91.1%.
From our split records and daily closes. Every recent split. Not investment advice.
$AIM discussion
Sign in to ask a question or join the discussion.